Myeloid Therapeutics
Dr. Gordon was born in South Africa, graduated in medicine at the University of Cape Town in 1961, and completed a doctorate in life sciences at Rockefeller University in 1971. Inspired by his research supervisor, Zanvil A Cohn, Dr. Gordon has studied macrophage immunobiology over the past 50 years, first at Rockefeller and later at the Sir William Dunn School of Pathology from 1976-2008.
Dr. Gordon was elected to the Fellowship of the Royal Society in 2007. His interests include the history of immunology and promoting science in South Africa, where he initiated an HIV education program.
This person is not in the org chart
This person is not in any offices
Myeloid Therapeutics
Myeloid Therapeutics is an immunology company focused on combining biology insights with cutting-edge technologies to harness myeloid cells and eradicate cancer and other diseases.